Company news
Bioasis Technologies Inc. news in 2017
Bioasis Technologies Inc.'s news releases, calls and decks from 2017, newest first.
Bioasis Implements Transition Plan for Its Board of Directors
December 4, 2017
Bioasis Establishes U.S. Presence with Office in Connecticut
October 10, 2017
biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board Advisor
October 2, 2017
biOasis Welcomes Dr. Nancy Stagliano, Dr. Deborah Rathjen and Dr. Maha Radhakrishnan to Its Board of Directors
September 25, 2017
biOasis Announces Voting Results for 2017 Annual Meeting
September 21, 2017
biOasis Announces Rob Hutchison, Founder, to Retire as Chairman & Board Member
September 18, 2017
biOasis Announces Formation of Scientific Advisory Board to Advance the Science for the Company’s Blood-Brain Barrier Drug Delivery Platform
September 7, 2017
biOasis Announces Nominees to the Board of Directors, Chairman Transition and Details of its Annual General Meeting of Shareholders
August 28, 2017
biOasis Appoints Doug Williams, MBA, Executive Vice President, Chief Business Officer
August 21, 2017
biOasis Appoints Catherine London, Executive Vice President, Head of Corporate Communications and Investor Relations
June 25, 2017
biOasis Engages FreeMind Group to Access Non-Dilutive Global Funding Opportunities
June 15, 2017
biOasis CEO Dr. Mark Day Releases Details of Corporate Plans in Message to Shareholders
June 13, 2017
biOasis to Present at The Global Chinese Financial Forum - Shanghai Conference 2017
June 8, 2017
biOasis to Present at the 16th International Postgraduate Course on Lysosomal Storage Disorders
June 4, 2017
biOasis Appoints Mark Day, Ph.D., as Chief Executive Officer and Director
April 24, 2017
biOasis Closes Oversubscribed Non-Brokered Private Placement
April 11, 2017
biOasis Announces Oversubscription of Financing
March 31, 2017
biOasis Provides AGM Update -- Expanding The biOasis Deal Flow Pipeline
January 22, 2017
biOasis Announces Assignment of IR Agreement
January 19, 2017